Search results
Oct 2, 2023 · “Katalin Karikó and Drew Weissman are brilliant researchers who represent the epitome of scientific inspiration and determination. Day after day, Dr. Weissman, Dr. Karikó and their teams worked tirelessly to unlock the power of mRNA as a therapeutic platform, not knowing the way in which their work could serve to meet a big challenge the world would one day face,” said Penn President Liz ...
Oct 1, 2021 · Dr. Katalin Karikó’s research has for decades focused on RNA-mediated mechanisms, with the ultimate goal of developing in vitro-transcribed mRNA for protein therapy. She investigated RNA-mediated immune activation and co-discovered (with Penn Medicine colleague Drew Weissman) that nucleoside modifications suppress the immunogenicity of RNA ...
Oct 6, 2023 · Katalin Karikó, a biochemist and researcher, started working on the science that made both of them possible in 1989. On Monday, Karikó, along with her collaborator Drew Weissman, won the Nobel ...
Oct 1, 2021 · Kati Karikó never doubted her research on mRNA would work, even if most people around her dismissed it. Karikó’s research and perseverance proved that mRNA vaccines were possible and paved the way for the Moderna and Pfizer-BioNTech vaccines to end the Covid-19 Pandemic. Katalin Karikó was born on January 17, 1955, in Hungary.
Katalin Karikó Adoptive T cell therapy is a form of cellular therapy that utilizes human immune cells, often empowered by the expression of recombinant proteins, to attack selected targets ...
Oct 2, 2023 · Katalin Karikó, a Hungarian biochemist, started working with mRNA as early as 1989; her research at the University of Pennsylvania in the mid-2000s laid the foundation for both the BioNTech and ...
Katalin Karikó (Szolnok, 17 de janeiro de 1955) é uma bioquímica húngara especializada em mecanismos mediados por RNA. Sua pesquisa tem sido o desenvolvimento de mRNA transcrito com vitro para terapias com proteínas.
